Cathy Chang

611 total citations
19 papers, 375 citations indexed

About

Cathy Chang is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Cathy Chang has authored 19 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Cathy Chang's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Cathy Chang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Cathy Chang collaborates with scholars based in United States and Czechia. Cathy Chang's co-authors include Megan McCausland, Rafi Ahmed, Aneesh K. Mehta, Carl W. Davis, Jens Wrammert, Mark J. Mulligan, Matthew S. Miller, Ali H. Ellebedy, Patrick C. Wilson and Srilatha Edupuganti and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Cathy Chang

17 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy Chang United States 8 212 169 99 64 64 19 375
Rosemarie D. Mason United States 13 145 0.7× 258 1.5× 148 1.5× 29 0.5× 35 0.5× 38 484
Amy Ransier United States 8 129 0.6× 137 0.8× 87 0.9× 48 0.8× 23 0.4× 13 316
Wilson Caparrós‐Wanderley United Kingdom 11 197 0.9× 190 1.1× 79 0.8× 33 0.5× 32 0.5× 17 399
Amanda L. Skarlupka United States 10 172 0.8× 77 0.5× 63 0.6× 19 0.3× 35 0.5× 16 255
Wanda G. H. Han Netherlands 15 274 1.3× 333 2.0× 181 1.8× 72 1.1× 46 0.7× 37 773
Bertrand Georges France 12 240 1.1× 259 1.5× 110 1.1× 36 0.6× 48 0.8× 26 529
Megan E. Gumina United States 6 437 2.1× 146 0.9× 179 1.8× 50 0.8× 40 0.6× 10 586
Sandeep Narpala United States 10 264 1.2× 367 2.2× 151 1.5× 114 1.8× 88 1.4× 14 681
Vanessa M. Cowton United Kingdom 11 196 0.9× 97 0.6× 157 1.6× 18 0.3× 59 0.9× 19 394
Wilbur Chen United States 4 157 0.7× 109 0.6× 58 0.6× 23 0.4× 23 0.4× 6 333

Countries citing papers authored by Cathy Chang

Since Specialization
Citations

This map shows the geographic impact of Cathy Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Chang more than expected).

Fields of papers citing papers by Cathy Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Chang. The network helps show where Cathy Chang may publish in the future.

Co-authorship network of co-authors of Cathy Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Chang. A scholar is included among the top collaborators of Cathy Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Chang. Cathy Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Lucas, Matthew C., Charles Xing, Cathy Chang, et al.. (2023). Abstract 1871: Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors. Cancer Research. 83(7_Supplement). 1871–1871. 1 indexed citations
3.
Frey, Gerhard, Jing Wang, Charles Xing, et al.. (2023). Abstract 1541: NextGen conditionally active biologic (CAB) anti-Nectin-4-ADC with improved stability and safety. Cancer Research. 83(7_Supplement). 1541–1541. 2 indexed citations
4.
Chen, Jian, Jing Wang, Cathy Chang, et al.. (2023). Abstract B022: Targeting senescence cells in cancer and aging by conditionally active biologic therapeutics. Cancer Research. 83(2_Supplement_1). B022–B022. 1 indexed citations
5.
Wang, Jing, Charles Xing, Matthew C. Lucas, et al.. (2021). Abstract 1870: Novel conditionally active bispecific T cell engagers targeting solid tumors. Cancer Research. 81(13_Supplement). 1870–1870. 1 indexed citations
6.
Davis, Carl W., Katherine Jackson, Megan McCausland, et al.. (2020). Influenza vaccine–induced human bone marrow plasma cells decline within a year after vaccination. Science. 370(6513). 237–241. 72 indexed citations
7.
Wang, Jing, Charles Xing, Matthew C. Lucas, et al.. (2020). Abstract 5698: Novel conditionally active bispecific T cell engagers targeting solid tumors. Cancer Research. 80(16_Supplement). 5698–5698. 2 indexed citations
8.
Wang, Jing, Charles Xing, Matthew C. Lucas, et al.. (2020). Abstract 4560: Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors. Cancer Research. 80(16_Supplement). 4560–4560. 4 indexed citations
9.
Chang, Cathy, Gerhard Frey, Leslie L. Sharp, et al.. (2019). Abstract 356: Novel conditionally active biologic (CAB) antibody targeting EpCAM demonstrates anti-tumor efficacy in vivo. Cancer Research. 79(13_Supplement). 356–356. 1 indexed citations
10.
Sharp, Leslie L., Cathy Chang, Gerhard Frey, et al.. (2019). Abstract 2708: Potent CAB CTLA4 antibody to reduce immune side effects and toxicities associated with single-agent and combination cancer immuno therapies. Cancer Research. 79(13_Supplement). 2708–2708. 1 indexed citations
11.
Sharp, Leslie L., Cathy Chang, Gerhard Frey, et al.. (2018). Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC. Cancer Research. 78(13_Supplement). 827–827. 16 indexed citations
12.
Rodón, Jordi, Matthew H. Taylor, Eileen M. O’Reilly, et al.. (2018). A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). TPS12126–TPS12126. 14 indexed citations
13.
Sullivan, Nicole, Eberhard Dürr, Carl W. Davis, et al.. (2018). Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. Journal of Virology. 92(14). 32 indexed citations
14.
Sharp, Leslie L., Cathy Chang, Gerhard Frey, et al.. (2018). Abstract 833: Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC. Cancer Research. 78(13_Supplement). 833–833. 15 indexed citations
15.
Chang, Cathy, Gerhard Frey, William J. Boyle, Leslie L. Sharp, & Jay M. Short. (2016). Abstract 3836: Novel conditionally active biologic anti-Axl antibody-drug conjugate demonstrates anti-tumor efficacy and improved safety profile. Cancer Research. 76(14_Supplement). 3836–3836. 2 indexed citations
16.
Rudek, Michelle A., et al.. (2014). Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure. Cancer Chemotherapy and Pharmacology. 73(4). 729–736. 17 indexed citations
17.
Ellebedy, Ali H., Florian Krammer, Guimei Li, et al.. (2014). Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proceedings of the National Academy of Sciences. 111(36). 13133–13138. 171 indexed citations
18.
Hall, Andrea, Elena Gorovits, Peter J. Syribeys, et al.. (2007). Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: Conditional expression and binding analysis. Microbial Pathogenesis. 43(2-3). 55–66. 22 indexed citations
19.
Wyborski, Denise L., Cathy Chang, Joe G. N. Garcia, et al.. (2004). Analysis of Organisms Surviving in Highly Contaminated Environments. eScholarship (California Digital Library). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosemarie D. Mason Breakdown of academic impact, for papers by Amy Ransier Breakdown of academic impact, for papers by Wilson Caparrós‐Wanderley Breakdown of academic impact, for papers by Amanda L. Skarlupka Breakdown of academic impact, for papers by Wanda G. H. Han Breakdown of academic impact, for papers by Bertrand Georges Breakdown of academic impact, for papers by Megan E. Gumina Breakdown of academic impact, for papers by Sandeep Narpala Breakdown of academic impact, for papers by Vanessa M. Cowton Breakdown of academic impact, for papers by Wilbur Chen
Rankless by CCL
2026